CA
Cherrystone Angel Group
Angel InvestorActiveProvidence based angel group interested in biopharma, medical device and tech startups in New England.
73
Investments
7
Exits
—
AUM
9.6%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Cherrystone Angel Group.
Investment Thesis & Strategy
Cherrystone Angel Group invests in early-stage biopharma, medical device, and tech startups in New England, with a focus on robotics/hardware and SaaS companies. They invest across various stages.
Investment Activity
Deals per year over the last 6 years
1
20162
20172
20183
20190
20202
2021Portfolio Companies
Selected investments from their portfolio of 73 companies
C
Cellino Biotech
Biotech · Series A, 2021
R
RemeGen
Biotech · Series C+, 2021
B
BioLabs
Other · Growth, 2019
S
Sonde Health
Healthcare · Series A, 2019
V
Vyne Therapeutics
Biotech · Series A, 2019
V
Vaxess Technologies
Biotech · Series B, 2018
A
Aegle Therapeutics
Biotech · Seed, 2018
E
EnsoData
Healthcare · Series A, 2017
X
XenoTherapeutics
Biotech · Seed, 2017
P
PathAI
AI/ML · Series B, 2016
Frequently Asked Questions
Cherrystone Angel Group focuses on Pre-seed, Seed stage investments.
Related Investors
Ted Mocarski
Providence, United States · 18 deals
Angel Street Capital
Providence, United States · 12 deals
Walker Williams
Providence, United States · 3 deals
Bruce Holland
Providence, United States · 2 deals
Mark Feinstein
Providence, United States · 2 deals
James Lombardi
Providence, United States · 1 deals